| Sarah E Davenport, MD | |
|
119 Belmont St, Worcester, MA 01605-2903 | |
| (508) 334-6206 | |
| (508) 334-6083 |
| Full Name | Sarah E Davenport |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 119 Belmont St, Worcester, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144372640 | NPI | - | NPPES |
| 110092823A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 057795 (Georgia) | Secondary |
| 208000000X | Pediatrics | 247061 (Massachusetts) | Primary |
| Entity Name | Cooper Pediatric Specialists, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306867585 PECOS PAC ID: 9335211317 Enrollment ID: O20080708000593 |
News Archive
A study with pre-school children has revealed just how potent and effective the power of advertising is.
Today Senate Majority Leader Harry Reid (D-Nev.) released his long awaited "manager's amendment" with new language dealing with the abortion issue. The new language is being trumpeted as including an opt-out provision that actually makes the opt-out provision in the original bill worse by requiring the state to either cover all abortions or opt out of all abortions.
Psychiatrists who are exposed to conflict-of-interest (COI) policies during their residency are less likely to prescribe brand-name antidepressants after graduation than those who trained in residency programs without such policies, according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania.
GlaxoSmithKline and Prosensa today announced that the first patient has commenced treatment in the Phase III clinical study investigating GSK2402968, in ambulant boys with Duchenne Muscular Dystrophy (DMD), who have a dystrophin gene mutation amenable to an exon 51 skip (up to 13% of boys with DMD). Commencement of this study confirms previously announced plans to progress this asset into Phase III.
Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah E Davenport, MD Po Box 415348, Boston, MA 02241-5348 Ph: (002) 258-8858 | Sarah E Davenport, MD 119 Belmont St, Worcester, MA 01605-2903 Ph: (508) 334-6206 |
News Archive
A study with pre-school children has revealed just how potent and effective the power of advertising is.
Today Senate Majority Leader Harry Reid (D-Nev.) released his long awaited "manager's amendment" with new language dealing with the abortion issue. The new language is being trumpeted as including an opt-out provision that actually makes the opt-out provision in the original bill worse by requiring the state to either cover all abortions or opt out of all abortions.
Psychiatrists who are exposed to conflict-of-interest (COI) policies during their residency are less likely to prescribe brand-name antidepressants after graduation than those who trained in residency programs without such policies, according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania.
GlaxoSmithKline and Prosensa today announced that the first patient has commenced treatment in the Phase III clinical study investigating GSK2402968, in ambulant boys with Duchenne Muscular Dystrophy (DMD), who have a dystrophin gene mutation amenable to an exon 51 skip (up to 13% of boys with DMD). Commencement of this study confirms previously announced plans to progress this asset into Phase III.
Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.
› Verified 3 days ago
Marissa E Parrillo, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 774-442-5545 Fax: 774-443-7042 | |
Dr. Penny M. Feldman, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 774-441-8081 Fax: 774-441-8055 | |
Dr. Linda D Sagor, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Department Of Pediatrics, Worcester, MA 01655 Phone: 508-856-4198 Fax: 508-856-1042 | |
Dr. Robert W Zavoski, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 26 Queen Street, Worcester, MA 01610 Phone: 508-860-7800 Fax: 508-860-7925 | |
Cornelius T Tyrrell, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Department Of Pediatrics, Worcester, MA 01655 Phone: 508-334-7986 Fax: 508-334-7989 | |
Callie M Stone, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-1000 | |
Nura El-haj, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 774-441-8083 Fax: 774-441-8057 |